SARASOTA, FL -- (MARKET WIRE) -- August 10, 2006 -- DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced the first scheduled sales of its improved DNAWITNESS product incorporating several improvements made to the Retinome testing process, now called Retinome 2.0, which offers improved iris color detection and allows crime scene investigators to develop samples in their own laboratories.
